GOOD JENNIFER L

CIK 00012292454 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001229245

Recent Transactions

50 trades

Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2026-06-24+2,324→ 2,324 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2026-06-24+3,691→ 3,691 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2026-06-23−4,712→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2026-06-23+4,712→ 11,712 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2026-02-19+675,000→ 675,000 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2025-06-24+4,712→ 4,712 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2025-06-24+7,037→ 7,037 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2025-06-18−4,000→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2025-06-18+4,000→ 7,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Performance Stock Option (right to buy)
2025-05-31+102,000→ 156,400 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2025-03-21$1.43/sh+5,263→ 218,576 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2025-03-21−5,263→ 0 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2025-03-21$6.58/sh−5,263→ 213,313 total
Award
Trevi Therapeutics, Inc.$TRVI
Performance Stock Option (right to buy)
2025-03-10+54,400→ 54,400 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2025-02-18+811,000→ 811,000 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-17$52.40/sh−31,751→ 3,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-17−15,000→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-17$22.93/sh+15,000→ 18,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-17−7,501→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-17$18.99/sh+7,501→ 34,751 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-17−9,250→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-17$21.37/sh+9,250→ 27,250 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-09$21.37/sh+4,305→ 20,205 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-09$18.99/sh+1,736→ 21,941 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-09$22.93/sh+12,900→ 15,900 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-09$4.15/sh+18,300→ 40,241 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-09−12,900→ 15,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-09−18,300→ 0 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-09−4,305→ 9,250 total
Sale
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-09-09$50.45/sh−37,241→ 3,000 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-09-09−1,736→ 7,501 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-09$3.04/sh−1,840→ 213,313 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-09-09−1,840→ 0 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-09$1.43/sh+1,840→ 215,153 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-06$3.03/sh−4,219→ 213,313 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-06$1.43/sh+4,219→ 217,532 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-09-06−4,219→ 1,840 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-05$1.43/sh+40,277→ 253,590 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-05$3.11/sh−40,277→ 213,313 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-09-05−40,277→ 6,059 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-04$1.43/sh+10,981→ 224,294 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-09-04−10,981→ 46,336 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-04$3.02/sh−10,981→ 213,313 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-03$3.02/sh−3,863→ 213,313 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-09-03$1.43/sh+3,863→ 217,176 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-09-03−3,863→ 57,317 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-08-26−1,700→ 18,300 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Common Stock
2024-08-26$4.15/sh+1,700→ 17,508 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-08-26−5,763→ 9,237 total
Exercise/Conversion
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Option (right to buy)
2024-08-26−2,100→ 27,900 total

Companies

Recent Filings

Address

C/O RHYTHM PHARMACEUTICALS, INC. 222 BERKELEY STREET, 12TH FLOOR

BOSTON, MA, 02116

View on SEC.gov